Oral Delivery of Chitosan Derivative-Based Nanoparticles Encapsulating Quercetin to Attenuate Intestinal Injury and Regulate Gut Microbiota Dysbiosis in Mucositis Treatment

MLA

Changhong Liu, et al. “Oral Delivery of Chitosan Derivative-Based Nanoparticles Encapsulating Quercetin to Attenuate Intestinal Injury and Regulate Gut Microbiota Dysbiosis in Mucositis Treatment.” ACS Food Science & Technology, vol. 1, Feb. 2021, pp. 399–409. EBSCOhost, https://doi.org/10.1021/acsfoodscitech.0c00121.

APA

Changhong Liu, Shuai Liu, Lifen Yin, Liyang Wei, Lei Zheng, Wenxiu Zheng, & Ling Yan. (2021). Oral Delivery of Chitosan Derivative-Based Nanoparticles Encapsulating Quercetin to Attenuate Intestinal Injury and Regulate Gut Microbiota Dysbiosis in Mucositis Treatment. ACS Food Science & Technology, 1, 399–409. https://doi.org/10.1021/acsfoodscitech.0c00121

Chicago

Changhong Liu, Shuai Liu, Lifen Yin, Liyang Wei, Lei Zheng, Wenxiu Zheng, and Ling Yan. 2021. “Oral Delivery of Chitosan Derivative-Based Nanoparticles Encapsulating Quercetin to Attenuate Intestinal Injury and Regulate Gut Microbiota Dysbiosis in Mucositis Treatment.” ACS Food Science & Technology 1 (February): 399–409. doi:10.1021/acsfoodscitech.0c00121.